首页> 美国卫生研究院文献>PLoS Clinical Trials >The Status of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Not Associated with the Effect of Anti-TNFα Agent Treatment in Patients with Rheumatoid Arthritis: A Meta-Analysis

【2h】

The Status of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Not Associated with the Effect of Anti-TNFα Agent Treatment in Patients with Rheumatoid Arthritis: A Meta-Analysis

机译：类风湿关节炎患者的类风湿因子和抗环瓜氨酸肽抗体状况与抗TNFα药物治疗效果无关：荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesThis meta-analysis was conducted to investigate whether the status of rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibody are associated with the clinical response to anti-tumor necrosis factor (TNF) alpha treatment in rheumatoid arthritis (RA).

机译：目的进行这项荟萃分析，以研究类风湿关节炎（RF）和抗环瓜氨酸肽（anti-CCP）抗体的状态是否与抗肿瘤坏死因子（TNF）α治疗的临床反应相关（ RA）。

著录项

期刊名称 PLoS Clinical Trials
作者
Qianwen Lv; Yufeng Yin; Xin Li; Guangliang Shan; Xiangni Wu; Di Liang; Yongzhe Li; Xuan Zhang;
展开▼
作者单位

展开▼
年(卷),期 2010(9),2
年度 2010
页码 e89442
总页数 10
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. IgM-Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide, and Anti-Citrullinated Human Fibrinogen Antibodies Decrease During Treatment with the Tumor Necrosis Factor Blocker Infliximab in Patients with Rheumatoid Arthritis. [J] . Vis M, Bos WH, Wolbink G, The Journal of rheumatology . 2008,第3期

机译：类风湿关节炎患者使用肿瘤坏死因子受体阻滞剂英夫利昔单抗治疗期间，IgM-类风湿因子，抗环瓜氨酸肽和抗瓜氨酸化人纤维蛋白原抗体减少。
2. Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis [J] . Ahmed Al-Shukaili, Saif Al-Ghafri, Sofia Al-Marhoobi, International journal of rheumatology . 2012,第Null期

机译：阿曼类风湿性关节炎患者抗突变型波形蛋白波形抗体，抗循环型波形肽抗体和类风湿因子的评估
3. Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies and rheumatoid factor in omani patients with rheumatoid arthritis [J] . International journal of rheumatology . 2012,第Null期

机译：抗突变型瓜氨酸波形蛋白抗体，抗环瓜氨酸肽抗体和类风湿因子在类风湿关节炎患者中的评估
4. Lack of response to classic treatment is associated with anti-cyclic citrullinated peptide antibodies but not with drb1-se status in patients with recent-onset rheumatoid arthritis [C] . Manzanares B., Martinez F., Gonzalez R., European Congress of Immunology . 2009

机译：缺乏对经典治疗的反应与抗循环瓜氨酸肽抗体有关，但近期发病类风湿性关节炎的患者没有使用DRB1-SE状态
5. Predictors of Infection in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents [D] . Liu, Tasia 2017

机译：类风湿关节炎患者使用抗肿瘤坏死因子药物的感染预测因子
6. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement [O] . C Alessandri, M Bombardieri, N Papa, 2004

机译：类风湿关节炎中抗TNFα治疗（英夫利昔单抗）后抗环瓜氨酸肽抗体和类风湿因子的减少与临床改善有关
7. The status of rheumatoid factor and anti-cyclic citrullinated peptide antibody are not associated with the effect of anti-TNFα agent treatment in patients with rheumatoid arthritis: a meta-analysis. [O] . Qianwen Lv, Yufeng Yin, Xin Li, 2014

机译：类风湿因子和抗环瓜氨酸肽抗体的状态与抗TNFα剂治疗类风湿性关节炎患者的效果无关：荟萃分析。

The Status of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Not Associated with the Effect of Anti-TNFα Agent Treatment in Patients with Rheumatoid Arthritis: A Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅